Rankings
▼
Calendar
▼
TLSA Q2 2022 Earnings Report — Tiziana Life Sciences Ltd Revenue & Financial Results | Market Cap Arena
Tiziana Life Sciences Ltd
TLSA
Q2 2022 Earnings
Reported June 30, 2022
Quarter Comparison
Revenue
Operating Income
EPS (Diluted)
Free Cash Flow
Metric
Q2 2022
Q1 2022
Q2 2021
QoQ Change
YoY Change
Revenue
$0
—
—
—
—
Op. Income
-$6M
—
—
—
—
EPS (Diluted)
$-0.11
—
—
—
—
Free Cash Flow
-$10M
—
—
—
—
marketcaparena.com
Income Statement
Item
Amount
REVENUE
$0
Cost of Revenue
-$62.0K
GROSS PROFIT
$62.0K
R&D Expenses
$10M
Selling & Marketing
$0
General & Administrative
$0
SG&A Expenses
-$6M
Other Expenses
$2M
Operating Expenses
$6M
Cost & Expenses
$6M
OPERATING INCOME
-$6M
Interest Income
$0
Interest Expense
$0
Other Income/Expenses
$44.5K
INCOME BEFORE TAX
-$6M
Income Tax Expense
$0
Net Income from Continuing Ops
-$6M
Net Income from Discontinued Ops
$0
Other Adjustments
$0
NET INCOME
-$6M
Net Income Deductions
$0
BOTTOM LINE NET INCOME
-$6M
D&A
$6.7K
EBIT
-$6M
EBITDA
-$6M
EPS
-$0
EPS Diluted
-$0
marketcaparena.com
Cash Flow Statement
Item
Amount
Net Income
-$4M
Depreciation & Amortization
$4.1K
Stock-Based Compensation
$0
Deferred Income Tax
$0
Other Non-Cash Items
-$5M
Change in Working Capital
-$1M
OPERATING CASH FLOW
-$10M
Capital Expenditure
$0
Acquisitions (Net)
$0
Purchases of Investments
$0
Sales/Maturities of Investments
$0
Other Investing Activities
-$3M
NET CASH FROM INVESTING
-$3M
Net Debt Issuance
$0
Common Stock Repurchased
$0
Common Dividends Paid
$0
Other Financing Activities
$0
NET CASH FROM FINANCING
$0
FREE CASH FLOW
-$10M
Net Change in Cash
-$22M
marketcaparena.com
← FY 2022
TLSA Overview
Q4 2022 →